CONMED Inc. (CNMD): Enterprise Value to EBITDA Ratio
CONMED Corporation (CNMD) minimizes risks through a broad portfolio of gastroenterology and orthopedic devices. The trajectory of the company's EV/EBITDA ratio demonstrates how scaling production reduces costs and sustains high margins. Rising demand for minimally invasive procedures and AirSeal systems acts as a powerful catalyst, with the current figure standing at 30.06, confirming the efficiency of its cash generation.
Comprehensive metric breakdowns and analytics for CONMED Corp (CNMD)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
CNMD - Net Financial Result|Projected Future Earnings CONMED Corporation|CNMD - Price to Earnings Ratio|Forward P/E Multiple conmed.com|CNMD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CONMED Corporation|CNMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months CONMED|CNMD - Earnings per share for the trailing year|Quarterly EPS earnings growth conmed.com|CNMD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year CONMED Corporation
- sales volume and revenue indicators:
Analysis of all company metrics:CONMED Corp CNMD
CONMED Corporation is systematically implementing environmental standards by reducing plastic packaging and optimizing energy consumption during instrument assembly. By analyzing the business valuation via EV/EBITDA, an investor can see the ratio of the company's total enterprise value, including debt, to its earnings before interest, taxes, depreciation, and amortization, which allows for a determination of the asset's fair market price relative to its operational efficiency and debt load.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|PLSE (pulsebiosciences.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio InMode (INMD)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Picard Medical Corp (PMI)|SRDX (Surmodics Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings SENS|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA Sanuwave Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR Inc) - EV/EBITDA Multiple|AVITA Medical, Inc (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio Baird Medical BDMD|EV/EBITDA Multiple EDAP (EDAP TMS SA)|EV/EBITDA Multiple Apyx Medical APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (TELA Bio Corp) - Enterprise Value to EBITDA Ratio|CytoSorbents Corp - Business Value to Operating Income Before Depreciation|SRTS (Sensus) - EV/EBITDA Multiple|Company Value to EBITDA Zynex Medical ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies Oxy B.H.N. Ltd. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
